Table 1 Clinical and biological characteristics of the patients.
From: A Belgian single centre outcome study of radioiodine treatment in adolescents with Graves’ disease
Parameter | Results/total number available data (%) |
|---|---|
Gender (Female) | 10/14 (71%) |
Presence of symptoms at diagnosis of GD | 11/12 (91%) |
Positive family history of thyroid disease | 9/12 (75%) |
Number of ATD courses | |
1 | 7/14 (50%) |
2 | 4/14 (29%) |
3 | 3/14 (21%) |
Total duration of ATD > 2 years | 8/14 (67%) |
Pubertal status at RAI | |
Prepubertal | 2/14 (14%) |
Pubertal | 7/14 (50%) |
Postpubertal | 5/14 (36%) |
BMI > 25 kg/m2 at RAI | 1/14 (7%) |
24 h 123 uptake at RAI < 50% | 1/11 (9%) |
Anti-TSHR antibodies after RAI | 10/10 (100%) |
